GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hoechst Pakistan Ltd (KAR:HPL) » Definitions » Research & Development

Hoechst Pakistan (KAR:HPL) Research & Development : ₨0 Mil (TTM As of Sep. 2024)


View and export this data going back to 2008. Start your Free Trial

What is Hoechst Pakistan Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Hoechst Pakistan's Research & Development for the three months ended in Sep. 2024 was ₨0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 was ₨0 Mil.


Hoechst Pakistan Research & Development Historical Data

The historical data trend for Hoechst Pakistan's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hoechst Pakistan Research & Development Chart

Hoechst Pakistan Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 40.52 38.73 41.11 58.92 71.92

Hoechst Pakistan Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Hoechst Pakistan Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₨0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hoechst Pakistan  (KAR:HPL) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Hoechst Pakistan Research & Development Related Terms

Thank you for viewing the detailed overview of Hoechst Pakistan's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Hoechst Pakistan Business Description

Traded in Other Exchanges
N/A
Address
Korangi Industrial Area, Plot 23, Sector 22, Karachi, PAK, 74900
Hoechst Pakistan Ltd is engaged in the manufacturing and selling of pharmaceutical and consumer healthcare products and vaccines.

Hoechst Pakistan Headlines

No Headlines